Vivos Therapeutics (VVOS) Payables (2019 - 2025)
Historic Payables for Vivos Therapeutics (VVOS) over the last 7 years, with Q3 2025 value amounting to $2.1 million.
- Vivos Therapeutics' Payables rose 9562.79% to $2.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.1 million, marking a year-over-year increase of 9562.79%. This contributed to the annual value of $1.1 million for FY2024, which is 4881.12% down from last year.
- According to the latest figures from Q3 2025, Vivos Therapeutics' Payables is $2.1 million, which was up 9562.79% from $1.8 million recorded in Q2 2025.
- Vivos Therapeutics' 5-year Payables high stood at $2.5 million for Q1 2024, and its period low was $644000.0 during Q3 2022.
- Over the past 5 years, Vivos Therapeutics' median Payables value was $1.3 million (recorded in 2021), while the average stood at $1.4 million.
- In the last 5 years, Vivos Therapeutics' Payables skyrocketed by 13726.71% in 2023 and then crashed by 5174.07% in 2025.
- Over the past 5 years, Vivos Therapeutics' Payables (Quarter) stood at $920000.0 in 2021, then soared by 53.37% to $1.4 million in 2022, then soared by 52.02% to $2.1 million in 2023, then crashed by 48.81% to $1.1 million in 2024, then skyrocketed by 91.53% to $2.1 million in 2025.
- Its Payables was $2.1 million in Q3 2025, compared to $1.8 million in Q2 2025 and $1.2 million in Q1 2025.